Burjeel Holdings, a prominent super-specialty healthcare group in the MENA region, has reported strong financial and operational growth for the financial year 2025, underlining the success of its long-term strategy and market-focused approach.
The group’s unaudited preliminary financial results for the 12-month period ending December 31, 2025, show revenue growth of 9.8%, reaching AED 5,501 million (INR 135.7 billion). Total patient visits increased by 8.4% year-on-year, exceeding 7 million across its healthcare network.
EBITDA increased by 19.9% to AED 1,089 million, with margins expanding to 19.8%, reflecting operational efficiencies and improved service mix. Net profit surged by 39.5% to AED 503 million, while net profit margins improved to 9.1%. The company recorded an exceptional performance in the fourth quarter, with net profit growth of nearly 160%.
Burjeel Holdings also reported strong clinical activity, with inpatient volumes growing by 11.7% and outpatient volumes by 8.3%. More than 89,700 surgeries were performed during the year across flagship facilities such as Burjeel Medical City, Medeor Hospital Abu Dhabi, Burjeel Hospital Abu Dhabi, and Lifecare Hospital Musaffah.
Commenting on the results, Dr. Shamsheer Vayalil, Chairman and CEO, said the growth was driven by investments in healthcare leadership, integrated care delivery, rising demand for complex care, and alignment with national healthcare priorities. He emphasized the group’s focus on expanding its presence beyond core markets while continuing to deliver world-class healthcare services and sustainable long-term value to shareholders.
